1492 related articles for article (PubMed ID: 18025205)
1. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
3. STAT3 promotes bone fracture healing by enhancing the FOXP3 expression and the suppressive function of regulatory T cells.
Sun G; Wang Z; Ti Y; Wang Y; Wang J; Zhao J; Qian H
APMIS; 2017 Aug; 125(8):752-760. PubMed ID: 28493494
[TBL] [Abstract][Full Text] [Related]
4. Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation.
Albert MH; Liu Y; Anasetti C; Yu XZ
Eur J Immunol; 2005 Sep; 35(9):2598-607. PubMed ID: 16078276
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling.
Elpek KG; Yolcu ES; Franke DD; Lacelle C; Schabowsky RH; Shirwan H
J Immunol; 2007 Dec; 179(11):7295-304. PubMed ID: 18025172
[TBL] [Abstract][Full Text] [Related]
6. G protein-coupled receptor 83 overexpression in naive CD4+CD25- T cells leads to the induction of Foxp3+ regulatory T cells in vivo.
Hansen W; Loser K; Westendorf AM; Bruder D; Pfoertner S; Siewert C; Huehn J; Beissert S; Buer J
J Immunol; 2006 Jul; 177(1):209-15. PubMed ID: 16785516
[TBL] [Abstract][Full Text] [Related]
7. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
[TBL] [Abstract][Full Text] [Related]
8. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
9. Requirement of CD28 signaling in homeostasis/survival of TGF-beta converted CD4+CD25+ Tregs from thymic CD4+CD25- single positive T cells.
Liu Y; Amarnath S; Chen W
Transplantation; 2006 Oct; 82(7):953-64. PubMed ID: 17038912
[TBL] [Abstract][Full Text] [Related]
10. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.
Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I
J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
12. IL-27 inhibits the development of regulatory T cells via STAT3.
Huber M; Steinwald V; Guralnik A; Brüstle A; Kleemann P; Rosenplänter C; Decker T; Lohoff M
Int Immunol; 2008 Feb; 20(2):223-34. PubMed ID: 18156621
[TBL] [Abstract][Full Text] [Related]
13. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice.
Carrier Y; Yuan J; Kuchroo VK; Weiner HL
J Immunol; 2007 Jan; 178(1):179-85. PubMed ID: 17182553
[TBL] [Abstract][Full Text] [Related]
14. CD4
Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
Delgado M; Chorny A; Gonzalez-Rey E; Ganea D
J Leukoc Biol; 2005 Dec; 78(6):1327-38. PubMed ID: 16204628
[TBL] [Abstract][Full Text] [Related]
16. Foxp3 expression in CD4
Zhu XW; Zhu HZ; Zhu YQ; Feng MH; Qi J; Chen ZF
J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):677-682. PubMed ID: 27752897
[TBL] [Abstract][Full Text] [Related]
17. STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease.
Laurence A; Amarnath S; Mariotti J; Kim YC; Foley J; Eckhaus M; O'Shea JJ; Fowler DH
Immunity; 2012 Aug; 37(2):209-22. PubMed ID: 22921119
[TBL] [Abstract][Full Text] [Related]
18. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.
Sugimoto N; Oida T; Hirota K; Nakamura K; Nomura T; Uchiyama T; Sakaguchi S
Int Immunol; 2006 Aug; 18(8):1197-209. PubMed ID: 16772372
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
[TBL] [Abstract][Full Text] [Related]
20. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma.
Liyanage UK; Goedegebuure PS; Moore TT; Viehl CT; Moo-Young TA; Larson JW; Frey DM; Ehlers JP; Eberlein TJ; Linehan DC
J Immunother; 2006; 29(4):416-24. PubMed ID: 16799337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
